-
IntroducedFeb 28, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
Stem Cell Therapy; Authorizing health care providers to perform stem cell therapy not approved by the United States Food and Drug Administration under certain circumstances; requiring health care providers to provide a specified written notice to patients before performing any stem cell therapy; requiring health care providers to obtain written consent from the patient or his or her representative before performing the therapy, etc.
Summary/Bill Text
Comments on SB 1768
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 28, 2025 | Senate
- Filed
Bill Texts
Documents